Skip to main content
OpenTrials
Completed

NCT Number: NCT06388473

Implementation of a Web-based App for Screening in Men in a Malaysian Primary Care Setting

The purpose of this study is to determine how to successfully implement ScreenMen in the primary care setting. ScreenMen is a mobile web-based app that has been developed to increase the uptake of screening in men. ScreenMen undertook a vigorous and systematic approach in its development. It was developed based on theories, evidence and needs of men. ScreenMen particularly target men in the age group of 20 to 50 years as this group of men usually do not attend any health screening. This research is necessary because ScreenMen has yet to be implemented in the primary care setting. The study will last about five months and your participation will be about five months.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Men's Health Screening Implementation Web-based Application

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Klinik Kesihatan Cheras Baru

Kuala Lumpur, 56100, Malaysia

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Healthcare providers that were involved in the clinic health screening program.
  • Patients who were aged 18 years and above were eligible to participate.

Exclusion criteria

  • Temporary healthcare providers (working in the clinic less than six months during the study period) and those who were away on leave.
  • Patients who did not understand Bahasa Malaysia, English or Mandarin, cognitively impaired, had an active psychiatric illness or were too ill.

Treatment and study plan

Tailored implementation intervention

Behavioral

The tailored implementation intervention comprised of six implementation strategies: 1) Involve executive boards, 2) Mandate change, 3) Provide education and training, 4) Identify and prepare champions, 5) The use of information and communication technology and 6) Audit and provide feedback.

Other names: ScreenMen

Primary outcomes

  1. Reach

    Time frame: Beginning of intervention

    Number of healthcare providers who attended the workshop / Number of healthcare providers who were invited to the workshop.

  2. Reach

    Time frame: Through study completion, 5 months.

    The number of patients who accessed ScreenMen.

  3. Adoption of ScreenMen using qualitative methods

    Time frame: 5 months into study

    Factors affecting the participation of healthcare providers in adopting ScreenMen in daily practice using qualitative interviews.

  4. Implementation of ScreenMen using qualitative methods

    Time frame: 5 months into study

    Factors affecting the implementation of ScreenMen daily practice using qualitative interviews.

  5. Maintenance of ScreenMen using qualitative methods

    Time frame: 5 months into study

    Intention to implement ScreenMen and factors influencing the decision using qualitative methods.

Secondary outcomes

  1. Impact of COVID-19 on the clinic using qualitative methods

    Time frame: 5 months into study

    The clinic situation during the COVID-19 pandemic and how it affected daily practice using qualitative methods.

Sponsors and collaborators

Lead sponsor

University of Malaya

Other

Registry information

Acronym: iScreenMen

Important dates

Study start
2021
Primary completion
2021
Study completion
2021
First posted
Apr 29, 2024
Registry last updated
Apr 29, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.